Dr. Nilesh Goswami, M.D.
Claim this profileSt. Johns Hospital
Studies Mitral Valve Regurgitation
Studies Aortic Valve Stenosis
7 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Nilesh Goswami, M.D. is currently running
Tendyne Transcatheter Mitral Valve System
for Mitral Regurgitation
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria
AltaValve
for Mitral Valve Regurgitation
Prospective, single-arm, multicenter study to evaluate the safety and performance of the AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.
Recruiting1 award N/A4 criteria
More about Nilesh Goswami, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Nilesh Goswami, M.D. has experience with
- Sentinel® Cerebral Protection System
- ACURATE Neo2™ Transfemoral TAVR System
- Medtronic CoreValve TAVR System
- Edwards SAPIEN 3 TAVR System
- ACURATE Prime™ Transfemoral TAVR System XL
- Tendyne Mitral Valve System
Breakdown of trials Nilesh Goswami, M.D. has run
Mitral Valve Regurgitation
Aortic Valve Stenosis
Aortic Stenosis
Heart Valve Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nilesh Goswami, M.D. specialize in?
Nilesh Goswami, M.D. focuses on Mitral Valve Regurgitation and Aortic Valve Stenosis. In particular, much of their work with Mitral Valve Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Nilesh Goswami, M.D. currently recruiting for clinical trials?
Yes, Nilesh Goswami, M.D. is currently recruiting for 3 clinical trials in Springfield Illinois. If you're interested in participating, you should apply.
Are there any treatments that Nilesh Goswami, M.D. has studied deeply?
Yes, Nilesh Goswami, M.D. has studied treatments such as Sentinel® Cerebral Protection System, ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System.
What is the best way to schedule an appointment with Nilesh Goswami, M.D.?
Apply for one of the trials that Nilesh Goswami, M.D. is conducting.
What is the office address of Nilesh Goswami, M.D.?
The office of Nilesh Goswami, M.D. is located at: St. Johns Hospital, Springfield, Illinois 62701 United States. This is the address for their practice at the St. Johns Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.